Authors: Manaka, A Sato, M Aoki, M Tanaka, M Ikeda, T Toda, Y Yamane, Y Nakaike, S

Citation: A. Manaka et al., 2-acylimino-3H-thiazoline derivatives: A novel template for platelet GPIIb/IIIa receptor antagonists, BIOORG MED, 11(8), 2001, pp. 1031-1035

Authors: Kaku, S Iwahashi, Y Kuraishi, A Albor, A Yamagishi, T Nakaike, S Kulesz-Martin, M

Citation: S. Kaku et al., Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation, NUCL ACID R, 29(9), 2001, pp. 1989-1993

Authors: Takaoka, A Tanaka, Y Tsuji, T Jinushi, T Hoshino, A Asakura, Y Mita, Y Watanabe, K Nakaike, S Togashi, Y Koda, T Matsushima, K Nishimura, T

Citation: A. Takaoka et al., A critical role for mouse CXC chemokine(s) in pulmonary neutrophilia during th type 1-dependent airway inflammation, J IMMUNOL, 167(4), 2001, pp. 2349-2353

Authors: Hirata, K Araya, J Nakaike, S Kitamura, K Ishida, T

Citation: K. Hirata et al., Side chain-dependent binding of antitumor indoloquinoxaline derivatives toDNA: Comparative spectroscopic and viscometric measurements, CHEM PHARM, 49(1), 2001, pp. 44-48

Authors: Fukuoka, K Yamagishi, T Ichihara, T Nakaike, S Iguchi, K Yamada, Y Fukumoto, H Yoneda, T Samata, K Ikeya, H Nanaumi, K Hirayama, N Narita, N Saijo, N Nishio, K

Citation: K. Fukuoka et al., Mechanism of action of aragusterol A (YTA0040), a potent anti-tumor marinesteroid targeting the G(1) phase of the cell cycle, INT J CANC, 88(5), 2000, pp. 810-819